A 61-year-old man, with a history of prior clear cell renal cell carcinoma in remission, was referred to 68Ga-DOTATATE PET/CT for the further evaluation of pancreatic tail mass. 68Ga-DOTATATE PET/CT showed pathologically intense uptake on the pancreatic mass; subsequent biopsy of the pancreatic mass confirmed the diagnosis of clear cell renal cell carcinoma metastasis. 68Ga-DOTATATE uptake is not specific for neuroendocrine tumors. In the presence of prior malignancy, it should be kept in mind that malignancies apart from neuroendocrine tumors express somatostatin receptors, and they can show 68Ga-DOTATATE uptake.
From the Departments of *Nuclear Medicine
†Medical Oncology, Ankara University Medical School, Ankara, Turkey.
Received for publication January 14, 2019; revision accepted June 1, 2019.
Conflicts of interest and sources of funding: none declared.
Correspondence to: Cigdem Soydal, MD, FEBNM, Department of Nuclear Medicine, Ankara University Medical Faculty, 06590, Cebeci, Ankara, Turkey. E-mail: email@example.com.
Online date: July 15, 2019